Ling Ling

Ling Ling

Auto-generated profile, based on publicly available information

Ling Ling

Key Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, Institute of Mass Spectrometry, School of Material Science and Chemical Engineering, Ningbo University, Ningbo, China

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2010 in Journal of Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
LLLing Ling
Ling Ling
SMSadasivam Murali
Sadasivam Murali
GSGary S Stein
Gary S Stein
Andre J. van WijnenAndre J. van Wijnen
Andre J. van Wijnen
SCSimon M. Cool
Simon M. Cool
Skeletal integrity is tightly regulated by the activity of osteoblasts and osteoclasts that are both under the control of extracellular glycosaminoglycans (GAGs) through their interactions with endogenous growth factors and differentiation‐promoting ligands. Receptor activator of NF‐kappa‐B ligand (RANKL), which is a tumor necrosis factor (TNF)‐related protein that is critical for osteoclast formation, is produced by osteoblasts and further modulated by certain types of GAGs. Using unfractionated osteoblast‐derived GAGs that reflect the complex tissue microenvironment within which osteoclasts reside, we demonstrate that these GAGs block the osteoclastogenic activity of RANKL. Furthermore, RANKL significantly reduces extracellular signal‐regulated protein kinase (ERK) activity, a putative suppressor of osteoclastogenesis, but osteoblast‐derived GAGs eliminate the inhibitory effects of RANKL on ERK activity. Notably, while imposing an anti‐osteoclastic effect, these GAGs also enhanced the proliferation of osteoblasts. Thus, the osteoblast microenvironment is a potent source of GAGs that promote bone anabolic activities. The anti‐osteoclastogenic and osteoblast‐related mitogenic activities of these GAGs together may provide a key starting point for the development of selective sugar‐based therapeutic compounds for the treatment of osteopenic disorders. J. Cell. Biochem. 109: 1222–1231, 2010.


1 December 2021 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
JSJiaojiao Sun
Jiaojiao Sun
LZLi Zhang
Li Zhang
YXYingchun Xu
Yingchun Xu
YXYuyan Xue
Yuyan Xue
LQLiang Qiao
Liang Qiao
SYShaoning Yu
Shaoning Yu

31 August 2006 in The International Journal of Advanced Manufacturing Technology
Verified
Journal Article
Closed access
PDF file
LLLing Ling
Ling Ling
YHYujin Hu
Yujin Hu
xuelin Wangxuelin Wang
xuelin Wang
CLChenggang Li
Chenggang Li

7 October 2022 in Talanta
Verified
Journal Article
Closed access
YLYang Li
Yang Li
HWHuanhuan Wang
Huanhuan Wang
FXFuxing Xu
Fuxing Xu
LLLing Ling
Ling Ling
CDChuan-Fan Ding
Chuan-Fan Ding

14 September 2021 in The Analyst
Verified
Journal Article
Closed access
PDF file
LLLing Ling
Ling Ling
SYShaoning Yu
Shaoning Yu
CDChuan-Fan Ding
Chuan-Fan Ding
A reactive MALDI matrix 4-hydrazinoquinazoline was used for the enhanced detection of both neutral and sialylated glycans via the dried-droplet method.